Form D · Other Health Care
SERA PROGNOSTICS, INC.
Salt Lake City, UT · CIK 0001534969
Offering snapshot reported May 11, 2021 · SEC filing
- Reported sold
- $100M Offering amount: $100M
- Investors reported
- 16 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Feb 23, 2021 As reported in this filing
Fundraising history
Reported soldDates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.
What changed?
Latest filing versus its linked predecessor, where available.
- Reported sold$61,500,000 → $100,299,976
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| May 11, 2021 | Amendment | $100,299,976 | $38,799,976vs Apr 5, 2021 | 16 | SEC filing |
| Apr 5, 2021 | Initial | $61,500,000 | No comparison | Not reported | SEC filing |
| Feb 27, 2020 | Amendment | $51,768,245 | $25,997,792vs Aug 7, 2019 | 28 | SEC filing |
| Aug 7, 2019 | Initial | $25,770,453 | No comparison | 18 | SEC filing |
| Mar 8, 2019 | Initial | $6,400,000 | No comparison | 1 | SEC filing |
| Dec 6, 2018 | Initial | $7,573,369 | No comparison | 12 | SEC filing |
| Jan 23, 2017 | Initial | $22,737,347 | No comparison | 5 | SEC filing |
| Nov 18, 2014 | Initial | $5,000,000 | No comparison | 15 | SEC filing |
| Jun 10, 2014 | Initial | $9,156,865 | No comparison | 15 | SEC filing |
| Mar 13, 2014 | Amendment | $4,500,000 | $3,250,000vs Oct 2, 2013 | 11 | SEC filing |
| Oct 2, 2013 | Initial | $1,250,000 | No comparison | 11 | SEC filing |
| Nov 20, 2012 | Amendment | $10,229,985 | $0vs Nov 21, 2011 | 15 | SEC filing |
| Nov 21, 2011 | Initial | $10,229,985 | No comparison | 15 | SEC filing |
Offering details
- Securities
- Equity, Debt, Option to acquire, Security to be acquired
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-394633
Source: Form D, filed May 11, 2021. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Elizabeth Canis | Director |
| Gregory C. Critchfield | Director, Executive |
| Dennis B. Farrar | Director |
| Douglas Fisher | Executive |
| Kim Kamdar | Director |
| Charles Kennedy | Director |
| Michael Minahan | Director |
| Mansoor Mirza | Director |
| Jay Moyes | Executive |
| Richard L. Novak | Director |
| Arnold Oronsky, Ph.D. | Director |
| Mark J. Ostrowski | Executive |
| Joshua Phillips | Director |
| Andrew A. Sauter | Executive |
| Joseph Siletto | Director |
| Ryan M. Trimble | Director |
| Marcus Wilson | Director |
Issuer details
Industry: Other Health Care (See others in industry)
Address:
2749 E. Parleys Way Suite 200
Salt Lake City, UT, 84109
Salt Lake City, UT, 84109